Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (Shenzhen Kangtai Biological)

四价流感病毒裂解疫苗（深圳康泰生物）

Report date: 2026/04/08 09:41:35

Base Information

Drug NameInfluenza Vaccine (Split Virion), Inactivated, Quadrivalent (Shenzhen Kangtai Biological)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza in BirdsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2026/03/17
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Kangtai Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Kangtai Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza in BirdsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A